EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology

Silvia López-Argüello, Maria Montaner, Alaa Rm Sayed, Antonio Oliver iD, Jürgen B Bulitta iD, Bartolome Moya iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01603-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Silvia López-Argüello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas aeruginosa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Direcció General de Política Universitària i Recerca, Govern Illes Balears.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β-lactam antibiotics have been successfully used for decades to combat susceptible Pseudomonas aeruginosa , which has a notoriously difficult to penetrate outer membrane (OM). However, there is a dearth of data on target site penetration and covalent binding of penicillin-binding proteins (PBP) for β-lactams and β-lactamase inhibitors in intact bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPseudomonas aeruginosaPenicillin-Binding ProteinsBacterial ProteinsNetwork PharmacologyMicrobial Sensitivity Testsbeta-LactamsImipenemCeftazidimebeta-Lactamases

Stichwörter der Autor:innen

Penicillin binding proteins (PBP)bacterial permeabilitybeta-lactams/beta-lactamase inhibitorsintact cellsouter membrane penetrationquantitative and systems pharmacology (QSP)

Substanzen

Penicillin-Binding ProteinsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsImipenemCeftazidimebeta-Lactamases

Autor:innen und Institutionen

  • Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.
  • Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Department of Chemistry, Faculty of Science, Fayoum University, Fayoum, Egypt.

ORCID-Profile: Antonio Oliver, Jürgen B Bulitta, Bartolome Moya

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • Direcció General de Política Universitària i Recerca, Govern Illes Balears
  • MEC | Instituto de Salud Carlos III
  • EC | European Regional Development Fund

Zitieren

APA

López-Argüello, S., Montaner, M., Sayed, A. R., Oliver, A., Bulitta, J. B., & Moya, B. (2023). Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01603-22

Vancouver

López-Argüello S, Montaner M, Sayed AR, Oliver A, Bulitta JB, Moya B. Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01603-22

BibTeX
@article{LpezArgello2023,
  author = {López-Argüello, Silvia and Montaner, Maria and Sayed, Alaa Rm and Oliver, Antonio and Bulitta, Jürgen B and Moya, Bartolome},
  title = {Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01603-22}
}
Kostenlos starten →